2026 MBA Summer Internship of Lilly China Leadership Development Program at Eli Lilly and Company

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Enrolled in an MBA program
Graduate by August 2027
Authorized to take internship job in China
Internship availability from mid-June 2026 to end of August 2026 (10 weeks)
Language fluency in Mandarin & English (both written and verbal)
Demonstrated leadership
Strong problem-solving skills
Teamwork and collaboration abilities
Strong resilience
Flexibility and adaptability
Strong learning agility

Responsibilities

Commit to an initial assignment in country of origin (China) to learn the industry and understand customers (patients, payers, and providers)
Leverage and develop leadership skills in home affiliate as part of global culture dedicated to employee development
Take on challenging assignments in Marketing, Finance, or Tech to deliver experiences to customers and promote leadership skills for future team leadership in Lilly’s International Business Unit

Skills

Marketing

Finance

Technology

Leadership Development

Business Strategy

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free